William Arscott, MD
Radiation Oncology · Tigard, ORNPI 1831509926
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,420 of the $15,843 with a category attached, or 97.3%. MIM Software Inc. accounts for 97.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $15,553 and has fallen 98.8% since, to $181 in 2024. Among radiation oncology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 6 payments — averaging $2640.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MIM Software Inc.$15K
- Boston Scientific$181
- GE HealthCare$150
- AstraZeneca$93
Across 1 payment — averaging $20,453 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$20K
What the payments were for
- Consulting fees$15,42097%
- Food & beverage$4233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MIM Software Inc. | 1 | $15,420 |
| Boston Scientific | 2 | $181 |
| GE HealthCare | 2 | $150 |
| AstraZeneca | 1 | $93 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Contour Protege AI$15,420
- SpaceOAR VUE System - 10mL$124
How this compares
$15,843 in reported general payments places this provider in the 95th percentile of 93 radiation oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 14 | $448 |
| Dexamethasone | 32 | $337 |
| Tamsulosin Hcl | 37 | $266 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Tigard
- John SchulerTigard$404
- Timur MitinHillsboro$58K
- Marka CrittendenPortland$20K
- Steven SeungPortland$11K
- Joshua WalkerPortland$9K
- Andrew KeePortland$7K
- Haidy LeeEugene$5K
- Brandon DyerPortland$4K
- Nima NabavizadehPortland$4K
- Amar SrivastavaPortland$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.